Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | PDCD4 | Q53EL6 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13041137 | 0.97 | ALDH1A1 (0.42) | ALDH1A1GPR84CA2MAPK1FFAR4 | |
| SCHEMBL2463439 | 0.97 | ALDH1A1 (0.42) | ALDH1A1GPR84CA2MAPK1FFAR4 | |
| SCHEMBL22249537 | 0.91 | GPR84 (0.50) | GPR84FFAR4FFAR1PDCD4NFKB1 | |
| SCHEMBL1228329 | 0.90 | GPR84 (0.48) | GPR84FFAR4FFAR1PDCD4NFKB1 | |
| SCHEMBL14533070 | 0.89 | GPR84 (0.44) | ALDH1A1GPR84CA2MAPK1FFAR4 | |
| SCHEMBL14533072 | 0.89 | GPR84 (0.44) | ALDH1A1GPR84CA2MAPK1FFAR4 | |
| SCHEMBL4378460 | 0.89 | GPR84 (0.44) | ALDH1A1GPR84CA2MAPK1FFAR4 | |
| SCHEMBL18719466 | 0.88 | GPR84 (0.33) | ALDH1A1GPR84FFAR4FFAR1PDCD4 | |
| SCHEMBL30787195 | 0.88 | GPR84 (0.52) | GPR84FFAR4FFAR1NFKB1 | |
| SCHEMBL6925758 | 0.88 | GPR84 (0.52) | GPR84FFAR4FFAR1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025694-A1 | Silicone Hydrogel Based Fluorescent Assay and Contact Lens | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025694-A1 | Silicone Hydrogel Based Fluorescent Assay and Contact Lens | CD44, CRYAA, IGFBP1 | ALDH1A1 3071/4885GPR84 391/4885CA2 1313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.